Touchstone Strategic Trust-Touchstone Anti-Benchmark US Core Equity Fund's Merck & Co Inc Holding Summary
As of 2023-09-30, Touchstone Strategic Trust-Touchstone Anti-Benchmark US Core Equity Fund held 4,306.00 shares of Merck & Co Inc(MRK), totaling $443,300.00. This investment constitutes 2.91% of their stock portfolio, and Touchstone Strategic Trust-Touchstone Anti-Benchmark US Core Equity Fund now holds 0% of the outstanding Merck & Co Inc(MRK) stock.
The initial trade took place in 2019Q3. And since then Touchstone Strategic Trust-Touchstone Anti-Benchmark US Core Equity Fund has made 6 purchases of MRK, at an average price of $82.49, for a total of 12,275.00 shares. In addition, there have been 5 sales at an average price of $89.67 for 7,969.00 shares. Based on historical transaction data and MRK's current price of $79.67, Touchstone Strategic Trust-Touchstone Anti-Benchmark US Core Equity Fund's estimated gain on his MRK holdings is $45,048.47, reflecting a 4.45% gain to date.
Touchstone Strategic Trust-Touchstone Anti-Benchmark US Core Equity Fund MRK ($79.67) Holding Chart
Touchstone Strategic Trust-Touchstone Anti-Benchmark US Core Equity Fund MRK ($79.67) Quarterly Buys and Sells
Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
---|---|---|---|---|
Shares Bought | 0 | Average Price $-/Share | ||
Shares Sold | 0 | Average Price $-/Share | ||
Current Price $0.00 | Total Estimated Gain 0 % |
Top Ranked Articles
- 1